S&P 500
(-0.17%) 5 460.15 points
Dow Jones
(-0.12%) 39 066 points
Nasdaq
(0.09%) 17 734 points
Oil
(-0.14%) $80.72
Gas
(-3.70%) $2.65
Gold
(-0.70%) $2 314.40
Silver
(0.15%) $28.91
Platinum
(1.99%) $1 006.00
USD/EUR
(0.29%) $0.936
USD/NOK
(0.75%) $10.68
USD/GBP
(0.48%) $0.792
USD/RUB
(0.00%) $87.49

के लिए वास्तविक समय के अद्यतन Uniqure NV [QURE]

एक्सचेंज: NASDAQ क्षेत्र: Healthcare उद्योग: Biotechnology
अंतिम अद्यतन26 Jun 2024 @ 20:58

-0.22% $ 4.45

Live Chart Being Loaded With Signals

Commentary (26 Jun 2024 @ 20:58):
Our systems believe the stock currently is undervalued by 0.33% compare to its pairs and should correct upwards.
Profile picture for Uniqure NV

uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B...

Stats
आज की मात्रा 130 059
औसत मात्रा 588 117
बाजार मूल्य 216.04M
EPS $-1.360 ( Q1 | 2024-05-07 )
अगली कमाई की तारीख ( $0 ) 2024-07-30
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -0.720
(Sector) 42.63
(Industry) 24.32
ATR14 $0.00900 (0.20%)
AADI -2.94%
ABCL 1.65%
ABCM 0.04%
ABEO -2.84%
ABIO -1.68%
ABOS 1.64%
ABSI 2.89%
ABUS -2.30%
ABVX -3.53%
ACAD -0.71%
ACER -17.95%
ACET -4.41%
ACGN 1.29%
ACHL -3.00%
ACHV -1.61%
ACIU -1.00%
ACLX 0.13%
ACRV -4.79%
ACST -1.63%
ACXP 0.65%
ADAG 4.64%
ADAP -2.91%
ADGI 0.87%
ADIL 0.54%
ADMA -2.68%
ADPT -0.30%
ADTX -3.47%
ADVM -3.91%
ADXN -1.60%
AEON -3.74%
AEZS -3.51%
AFMD -1.40%
AGEN -1.82%
AGIO -2.10%
AGLE 6.66%
AGTC 0.00%
AIKI 0.85%
AIMDW -13.88%
AKBA -3.12%
AKRO -2.81%
AKTX 4.08%
AKUS 0.00%
ALBO 0.00%
ALDX -2.40%
ALEC -2.29%
ALGS -2.41%
ALKS -0.21%
ALLK -9.32%
ALLO -5.87%
ALLR -3.22%
ALNA 3.16%
ALNY 1.95%
ALPN 0.02%
ALPX 0.00%
ALRN -0.33%
ALT -9.65%
ALVR -0.56%
ALXN 0.00%
ALXO -10.96%
ALZN 4.78%
AMRN -0.31%
AMTI -3.13%
ANAB 0.46%
ANEB -1.52%
ANGN 0.00%
ANIX -1.62%
ANL -6.60%
ANNX -0.66%
ANPC -3.15%
APGE -0.91%
APGN 8.48%
APGNW 30.65%
APLM 1.56%
APLS 0.09%
APLT -4.50%
APM -1.47%
APOP 0.38%
APRE 2.29%
APTO 3.27%
APTX 3.17%
APVO 0.18%
ARAV -13.39%
ARCT -3.90%
ARDS -14.23%
ARDX -0.58%
ARGX -0.73%
ARNA 0.00%
ARPO -0.90%
ARQT -0.52%
ARTL -2.50%
ARTLW 0.00%
ARVN 5.76%
ARWR -1.56%
ASLN -5.04%
ASMB -7.14%
ASND -0.94%
ATAI -1.48%
ATHA 5.94%
ATHE 1.12%
ATHX -33.50%
ATNF 0.99%
ATOS 2.90%
ATRA -2.93%
ATXI 1.93%
ATXS -1.00%
AUPH -1.17%
AURA 1.17%
AUTL -1.58%
AVBP -2.86%
AVEO 0.00%
AVIR -0.15%
AVRO -1.41%
AVTE -5.48%
AVTX -1.25%
AVXL -2.72%
AXLA 0.00%
AXSM -1.99%
AYLA 0.00%
AZRX 2.07%
BBI 2.17%
BBIO 0.96%
BCAB 1.95%
BCDA -2.07%
BCDAW -41.77%
BCEL 0.00%
BCLI 7.14%
BCRX 1.32%
BCTX 7.65%
BCTXW -16.29%
BCYC 1.10%
BDRX -3.52%
BDTX -0.43%
BEAM 0.49%
BFRA -2.91%
BGNE -2.72%
BIOR -3.40%
BIVI 2.05%
BLCM -6.68%
BLI -5.88%
BLPH 0.00%
BLRX -0.85%
BLTE -0.62%
BLU 0.03%
BLUE -0.71%
BMEA -9.88%
BMRN 0.38%
BNOX -2.22%
BNTC -2.11%
BNTX -1.47%
BOLD -8.11%
BOLT 1.31%
BPMC -1.21%
BPTH 1.86%
BPTS -13.47%
BRNS -0.74%
BRTX -2.36%
BTAI 22.88%
BTTX 53.33%
BTX 0.05%
BVXV 0.74%
BXRX 7.39%
BYSI 3.39%
CABA 0.35%
CADL -1.42%
CALA 0.00%
CALC -1.77%
CALT -0.59%
CAPR -2.80%
CARA 0.21%
CARM 12.17%
CASI -1.67%
CATB -6.97%
CBAY 0.03%
CBIO -2.65%
CBLI -7.31%
CBUS -6.16%
CCCC -5.21%
CCXI 0.00%
CDAK 0.00%
CDIO -2.02%
CDIOW 24.00%
CDMO -2.82%
CDMOP 0.04%
CDT -10.57%
CDTTW -39.60%
CDTX -1.92%
CDXC 0.00%
CDXS 6.07%
CELC -4.25%
CELU -1.50%
CELUW 11.80%
CERC -1.68%
CERE -0.96%
CERO -4.50%
CEROW -10.18%
CFRX -27.95%
CGEM -2.62%
CGEN -3.31%
CGON -0.54%
CGTX -5.11%
CHMA -6.00%
CHRS -0.63%
CINC 0.00%
CING 2.56%
CINGW 34.95%
CKPT -2.87%
CLBS -16.75%
CLDX -2.32%
CLGN 0.34%
CLLS -4.15%
CLNN 2.42%
CLNNW 0.00%
CLRB 7.04%
CLSD 1.02%
CLSN -0.68%
CLVS 0.00%
CMMB -0.01%
CMND 3.63%
CMPI 0.00%
CMPX -7.50%
CMRA 0.00%
CMRAW 33.33%
CMRX -2.71%
CNCE 0.00%
CNSP -39.08%
CNST 0.00%
CNTA -0.67%
CNTB -2.25%
CNTX -6.85%
COCP -2.02%
COEPW 32.45%
COGT -2.82%
CORT 2.20%
COYA -1.46%
CPRX -0.99%
CRBP -1.88%
CRBU -4.83%
CRDF -2.20%
CRGX 1.28%
CRIS -0.38%
CRNX -5.81%
CRSP 0.93%
CRTX 2.63%
CRVO -2.50%
CRVS 1.12%
CSBR -1.59%
CTCX -1.63%
CTIC 0.06%
CTMX -3.31%
CTNM -1.35%
CTXR 2.03%
CUE 3.53%
CVAC -2.26%
CVKD -5.23%
CWBR 2.80%
CYAD -12.96%
CYCC 10.09%
CYCCP 5.49%
CYCN 0.43%
CYT -2.27%
CYTK -1.99%
CYTO -2.73%
DARE 6.41%
DAWN 0.52%
DBTX -0.81%
DBVT 4.44%
DFFN 10.28%
DICE 0.06%
DMAC 34.01%
DNLI -1.43%
DNTH -6.02%
DOMH -1.58%
DRMA -1.10%
DRMAW -1.25%
DRNA 0.00%
DRTS 1.85%
DRTSW 0.00%
DRUG 0.95%
DSGN -1.21%
DTIL 1.36%
DYAI 9.68%
EARS -1.77%
EDIT -2.52%
EDSA -1.00%
EFTR 8.18%
EFTRW -51.85%
EIGR -9.21%
ELAB -1.00%
ELDN 7.98%
ELEV -4.98%
ELOX 7.69%
ELTX -0.88%
ELVN -4.05%
ELYM 1.05%
ENGN 1.67%
ENGNW 0.12%
ENLV 2.54%
ENOB 1.79%
ENSC 4.13%
ENTA -0.49%
ENTO -4.42%
ENTX 0.69%
ENVB 1.10%
EPIX -0.10%
EPRX -2.97%
EPZM 0.00%
EQ 0.86%
EQRX -2.09%
EQRXW 0.00%
ERAS -1.44%
ERNA 0.00%
ERYP 1.30%
ESLA 4.30%
ESLAW 87.05%
ETNB -1.02%
ETON 1.68%
ETTX 0.00%
EVAX -2.14%
EVGN 3.88%
EVLO 0.00%
EWTX 0.00%
EXAI -0.57%
EXEL -0.36%
EYEG -0.69%
EYEN 1.48%
EYPT -0.24%
FATE -7.80%
FBIO 0.59%
FBIOP 0.92%
FBLG -14.30%
FBRX -0.04%
FDMT -4.82%
FENC -0.97%
FGEN -5.56%
FHTX 2.10%
FIXX 0.77%
FMTX 0.00%
FNCH 8.87%
FOLD -2.58%
FREQ 4.76%
FRLN 0.15%
FRTX 0.00%
FSTX 0.00%
FTRE -0.31%
FULC -3.34%
FUSN 0.00%
FWBI 4.59%
FWP 0.00%
GALT -6.28%
GANX -1.49%
GBIO -2.12%
GBT 0.01%
GDTC 0.50%
GERN -4.31%
GHRS -1.59%
GLMD -2.32%
GLPG -2.26%
GLSI 2.80%
GLTO -0.57%
GLUE -2.36%
GLYC -10.00%
GMAB -0.43%
GMDA -18.25%
GMTX 0.00%
GNCA -85.71%
GNFT -2.92%
GNLX 1.33%
GNPX 0.00%
GNTA 3.94%
GOSS -9.83%
GOVX 7.27%
GOVXW -49.04%
GPCR -6.48%
GRAY -10.80%
GRCL 0.05%
GRNA -0.03%
GRNAW 8.91%
GRPH -2.75%
GRTS -0.08%
GRTX 0.00%
GTHX 0.68%
GUTS -5.31%
GXGXW 41.67%
GYRE -7.16%
HALO -1.15%
HARP 0.09%
HCWB -3.75%
HEPA 2.80%
HGEN -84.62%
HILS 5.66%
HLVX -0.57%
HOOK 0.80%
HOTH -2.70%
HOWL -2.14%
HRMY 0.85%
HRTX 2.63%
HSTO 0.00%
HUMA 1.32%
HUMAW -0.01%
IBRX -3.78%
ICCC 0.22%
ICPT 0.21%
ICU 16.49%
ICUCW 20.20%
ICVX -0.91%
IDRA -23.04%
IDYA -1.94%
IFRX -1.85%
IGMS -0.15%
IKNA 0.30%
IKT 1.42%
IMAB -0.58%
IMCR -2.61%
IMGN 0.02%
IMGO 0.00%
IMMP 4.55%
IMMX -6.90%
IMNM -1.65%
IMNN 0.88%
IMPL -27.27%
IMRA 15.96%
IMRN -1.18%
IMRX 0.00%
IMTX -1.58%
IMTXW 6.00%
IMUX 1.56%
IMV 0.00%
IMVT -3.68%
INAB 0.00%
INBX 0.53%
INCY -0.86%
INDP 11.07%
INFI -52.38%
INKT -0.01%
INM -2.20%
INMB 3.01%
INO -2.21%
INSM -0.85%
INTS -2.75%
INVA 0.22%
INZY 0.92%
IOBT -11.42%
IONS 0.40%
IOVA -2.31%
IPA 2.46%
IPHA 5.58%
IPSC -2.15%
IRON -2.54%
ISEE 0.38%
ITOS -1.50%
ITRM 1.67%
IVA 6.96%
IVVD -3.72%
JAGX 1.05%
JANX -4.03%
JAZZ -0.74%
JNCE 0.00%
JSPR -6.10%
JSPRW 20.88%
JUNS 0.00%
JUNSW 0.00%
KA -3.94%
KALV -1.95%
KDNY 0.22%
KMPH -0.34%
KNSA -2.85%
KNTE -0.38%
KOD -7.11%
KPRX 0.96%
KPTI -1.38%
KRBP -10.00%
KRON 1.05%
KROS -1.20%
KRRO -6.34%
KRTX 0.03%
KRYS -0.90%
KTRA 18.60%
KTTA 8.16%
KTTAW 0.92%
KURA -1.83%
KYMR -2.41%
KYTX -4.46%
KZIA 5.16%
KZR -1.49%
LABP 0.57%
LBPH -1.71%
LBPS 0.00%
LBPSW 14.81%
LEGN 1.65%
LENZ -3.36%
LEXX 0.00%
LEXXW -14.63%
LGND -1.30%
LGNDV 0.00%
LGVN -9.61%
LIAN -8.28%
LIFE 2.70%
LIPO -7.10%
LIXT -5.24%
LIXTW 63.57%
LJPC -0.32%
LMNL 0.12%
LOGC 0.61%
LPCN -4.05%
LPTX -1.10%
LQDA -0.33%
LRMR -1.92%
LSTA -4.06%
LTRN 1.76%
LUMO -1.32%
LVTX 0.00%
LXEO -4.33%
LXRX -2.06%
LYEL -34.44%
LYRA 2.33%
MACK 0.10%
MBIO -9.32%
MBRX -1.72%
MCRB 1.76%
MDGL -2.70%
MDNA -13.16%
MDWD 0.10%
MDXG -2.58%
MEIP -0.13%
MESO -1.78%
MGNX -3.03%
MGTA -7.74%
MGTX -2.97%
MGX -2.68%
MIRM -1.80%
MIRO 0.59%
MIST 1.54%
MITO 0.00%
MLEC -7.69%
MLECW 2.31%
MLND -5.36%
MLTX -0.63%
MLYS -5.79%
MNKD -1.15%
MNMD 0.21%
MNOV 2.11%
MNPR -5.01%
MOLN 0.28%
MOR 1.29%
MORF -3.86%
MREO -5.00%
MRKR 2.68%
MRNA -4.81%
MRNS -4.04%
MRSN -2.62%
MRTX -0.17%
MRUS 0.13%
MRVI -1.82%
MTCR -1.29%
MTEM 4.46%
MTP -18.50%
MURA -1.24%
MYMD 8.38%
NAMS 1.37%
NAMSW 0.43%
NAUT 1.15%
NBRV 0.71%
NBSE -1.56%
NBTX 8.61%
NCNA 1.09%
NERV -1.90%
NEXI 2.60%
NGM -1.28%
NGNE -2.03%
NKGN 6.78%
NKGNW 8.00%
NKTR -4.21%
NKTX -4.57%
NLSP -2.82%
NLSPW 26.67%
NMRA -1.32%
NMTR -42.97%
NOVN -24.84%
NRBO 12.08%
NRIX -0.34%
NRSN -7.05%
NRSNW 0.00%
NRXP -4.09%
NRXPW 18.33%
NRXS 4.82%
NTBL 5.06%
NTEC -12.45%
NTHI 0.00%
NTLA -6.13%
NTRBW -31.07%
NUVL -2.00%
NVAX -2.21%
NVCT 3.59%
NVIV -34.28%
NXTC -2.94%
NYMX -0.05%
OABI 0.13%
OABIW -10.06%
OBIO -2.48%
OBSV 0.00%
OCEA 0.00%
OCGN 3.81%
OCS -1.02%
OCUL -2.21%
OCUP 1.96%
ODT -4.27%
OKYO 1.51%
OLMA -5.29%
OMER -1.28%
OMGA 5.00%
ONCO 5.04%
ONCR -3.08%
ONCS 31.87%
ONCT -1.87%
ONCY 0.99%
ONTX -0.47%
ONVO 0.99%
OPNT 0.00%
OPT 3.09%
ORGS -2.07%
ORIC -3.56%
ORMP 15.18%
ORPH 0.00%
ORTX 0.30%
OSMT -1.77%
OTIC -92.64%
OTLK -1.81%
OVID -1.44%
OYST 0.00%
PALI -0.87%
PASG -1.30%
PBLA -7.50%
PBM -6.75%
PBYI 1.69%
PCSA 0.00%
PCVX -0.34%
PDSB -2.52%
PEPG 0.27%
PGEN -3.04%
PHAR 1.51%
PHAS 0.00%
PHAT -1.06%
PHIO -3.57%
PHIOW 36.47%
PHVS -7.22%
PHXM -5.20%
PIRS 0.58%
PKBO 0.00%
PKBOW 999 900.00%
PLRX -1.10%
PLUR 6.01%
PMN 0.72%
PMVP -1.19%
PNT 0.16%
PPBT -4.26%
PRAX 0.63%
PRDS 0.93%
PRLD 0.00%
PROG -3.47%
PROK 0.00%
PRQR -0.01%
PRTA -2.65%
PRTC 0.49%
PRTG -0.50%
PRTK 1.83%
PRVB 0.00%
PSTI -2.91%
PSTV -6.04%
PSTX -0.97%
PTCT -0.28%
PTE -0.82%
PTGX -1.76%
PTIXW -49.04%
PULM 2.60%
PXMD 0.00%
PYPD 0.07%
PYXS 1.96%
QLGN -3.72%
QNCX 5.70%
QNRX 0.37%
QSI -11.97%
QSIAW -3.13%
QTTB -4.54%
QURE -0.22%
RAIN -1.63%
RANI 6.42%
RAPT -2.92%
RARE 1.41%
RCKT -7.76%
REGN -0.70%
RENB -3.42%
REPL -2.61%
RETA 0.02%
REUN -0.89%
REVB -1.51%
REVBU 3.46%
REVBW 4.38%
RGLS -4.91%
RGNX -5.44%
RIGL -3.29%
RLAY -4.68%
RLMD 0.33%
RLYB 0.00%
RNA -0.49%
RNAC -5.65%
RNAZ -0.96%
RNXT 1.88%
ROIV -2.08%
ROIVW 4.56%
RPHM 0.00%
RPRX -0.06%
RPTX -2.93%
RUBY 2.70%
RVLP -32.05%
RVMD -1.20%
RVMDW -30.00%
RVNC 2.34%
RVPH -1.58%
RVPHW 1.62%
RXDX 0.09%
RXRX -3.46%
RYTM -6.51%
RYZB 0.02%
RZLT 1.68%
SABS -1.37%
SABSW -11.81%
SAGE 1.56%
SANA -3.88%
SAVA -0.31%
SAVAW 0.00%
SBBP 1.52%
SBTX 1.03%
SCNI 5.50%
SCPH 0.00%
SCPS 0.00%
SEEL -4.48%
SEER 0.00%
SELB -8.00%
SESN 7.29%
SGEN -0.07%
SGMO -1.03%
SGMT -1.69%
SGTX -2.56%
SIOX 22.63%
SLDB -7.07%
SLGL 4.00%
SLN -4.21%
SLNO -4.03%
SLRX 6.04%
SLS -2.58%
SMMT -3.00%
SNDX 0.87%
SNGX -4.52%
SNPX -0.81%
SONN -1.08%
SPPI -0.49%
SPRB 0.32%
SPRC -4.17%
SPRO 0.30%
SRNE -34.00%
SRPT -1.44%
SRRA 0.00%
SRRK -2.79%
SRZN -2.45%
STAB 0.00%
STOK -5.09%
STRO -2.84%
STSA 0.00%
STTK -4.78%
SURF -0.93%
SVRA -3.29%
SWTX 0.34%
SYBX -1.94%
SYRS -1.72%
TALS -0.73%
TARA -7.57%
TARS -0.23%
TBPH 0.60%
TCBP 2.73%
TCDA 0.00%
TCON -2.03%
TCRR 0.00%
TCRT 1.59%
TCRX 2.58%
TECH -0.14%
TENX -1.27%
TERN -7.72%
TFFP -3.05%
TGTX -2.97%
THRX 0.12%
TIL -0.20%
TLC 0.00%
TLSA -3.09%
TNGX -2.16%
TNXP -6.39%
TNYA -7.02%
TPST 2.87%
TRDA -3.93%
TRVI 1.15%
TRVN 2.92%
TSHA -24.34%
TSVT -2.79%
TTNP -9.27%
TVTX 0.63%
TYRA -7.01%
UBX -2.12%
UNCY -2.43%
URGN -1.00%
UTHR -0.39%
VACC 11.36%
VALN -2.89%
VAXX 87.50%
VBIV 0.78%
VBLT -8.77%
VCEL 0.09%
VCNX 10.35%
VCYT -1.23%
VERA -2.55%
VERU 0.79%
VERV -2.96%
VIGL 5.11%
VINC 1.62%
VIR 0.54%
VIRI -1.57%
VIRX 2.40%
VKTX -1.67%
VLON -13.04%
VNDA -2.20%
VOR -2.02%
VRCA -0.07%
VRDN -4.31%
VRNA -1.40%
VRPX 0.38%
VRTX 0.39%
VSTM -3.58%
VTGN -0.45%
VTVT -2.97%
VTYX -0.21%
VXRT -2.90%
VYGR -1.53%
VYNE -3.47%
VYNT 7.78%
WINT -3.24%
WVE -4.51%
XBIO 0.93%
XBIT 1.77%
XCUR 3.58%
XENE -2.85%
XERS 2.38%
XFOR 2.62%
XLO 2.00%
XLRN 0.00%
XNCR 0.47%
XOMA -3.57%
XOMAO 0.36%
XOMAP -0.82%
XRTX -8.92%
YMAB -1.80%
ZGNX 0.00%
ZIOP -0.88%
ZLAB -3.51%
ZNTL -2.33%
ZSAN 0.00%
Insider Trading
Date Person Action Amount type
2024-06-19 Gut Robert Buy 8 080 Ordinary Shares
2024-06-19 Gut Robert Buy 15 840 Stock Option (Right to Buy)
2024-06-19 Springhorn Jeremy P. Buy 8 080 Ordinary Shares
2024-06-19 Springhorn Jeremy P. Buy 15 840 Stock Option (Right to Buy)
2024-06-19 Meek David D. Buy 8 080 Ordinary Shares
INSIDER POWER
73.52
Last 98 transactions
Buy: 1 886 320 | Sell: 306 528
सहसंबंध (AI algo v.1.1b): Undervalued: 0.33% $4.46 paired level. (एल्गो वास्तविक समय में सबसे अधिक सहसंबंधित स्टॉक्स के परिवर्तनों का ट्रैक करता है और तत्काल अद्यतन देता है)

मात्रा सहसंबंध

लंबा: -0.06 (neutral)
छोटा: 0.57 (weak)
Signal:(70.645) Neutral

Uniqure NV सहसंबंध

10 सबसे अधिक सकारात्मक सहसंबंध
RIVN0.9
NVTS0.9
MAXN0.896
SPWR0.892
BIGC0.89
RUN0.888
BGFV0.884
VMAR0.883
NVEE0.881
NARI0.88
10 सबसे अधिक नकारात्मक सहसंबंध
ESTA-0.864
DXJS-0.844
BSCO-0.84
PRAX-0.838
PNTG-0.838
JVA-0.835
SWAV-0.832
WDC-0.832
NTRA-0.83
MDWD-0.827

क्या आप जानते हैं?

कोरलेशन एक सांख्यिकीय माप है जो दो चरों के बीच संबंध का वर्णन करता है। यह -1 से 1 तक का होता है, जहाँ -1 एक पूर्ण नकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा कम होता है), 1 एक पूर्ण सकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा भी बढ़ता है) और 0 कोई कोरलेशन नहीं होता है (चरों के बीच कोई संबंध नहीं है)।

कोरलेशन किसी भी दो चरों के बीच संबंध का विश्लेषण करने के लिए इस्तेमाल किया जा सकता है, न कि केवल स्टॉक में। यह वित्तीय, अर्थशास्त्र, मनोविज्ञान और अन्य क्षेत्रों में आमतौर पर उपयोग किया जाता है।

Uniqure NV सहसंबंध - मुद्रा/वस्त्र

The country flag -0.67
( moderate negative )
The country flag -0.47
( neutral )
The country flag 0.00
( neutral )
The country flag -0.62
( weak negative )
The country flag 0.67
( moderate )
The country flag -0.74
( moderate negative )

Uniqure NV वित्तीय

Annual 2023
राजस्व: $15.84M
सकल लाभ: $2.22M (13.98 %)
EPS: $-6.47
FY 2023
राजस्व: $15.84M
सकल लाभ: $2.22M (13.98 %)
EPS: $-6.47
FY 2022
राजस्व: $106.48M
सकल लाभ: $103.14M (96.86 %)
EPS: $-2.71
FY 2021
राजस्व: $524.00M
सकल लाभ: $499.03M (95.23 %)
EPS: $7.17

Financial Reports:

No articles found.

Uniqure NV Options Data

Calls

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Puts

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Uniqure NV

uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy that is in Phase I/II clinical study for the treatment of Huntington's disease; AMT-060, which is in Phase I/II clinical trial for the treatment of hemophilia B; AMT-210, a product candidate for the treatment of Parkinson's disease; AMT-260 for temporal lobe epilepsy; AMT-240, a preclinical product candidate for the treatment of autosomal dominant Alzheimer's disease; and AMT-161 for the treatment of amyotrophic lateral sclerosis. uniQure N.V. was founded in 1998 and is headquartered in Amsterdam, the Netherlands.

के बारे में लाइव सिग्नल्स

इस पृष्ठ पर प्रस्तुत लाइव सिग्नल्स NA को कब खरीदना या बेचना है, इसका निर्धारण करने में मदद करते हैं। सिग्नल्स में 1-मिनट की देरी हो सकती है; सभी बाजार सिग्नल्स की तरह, त्रुटि या गलतियों की संभावना होती है।

लाइव ट्रेडिंग सिग्नल्स स्थायी नहीं हैं, और getagraph.com इन सिग्नल्स पर किए गए किसी भी कार्रवाई के लिए जिम्मेदारी नहीं रखते हैं, जैसा कि उपयोग की शर्तें में वर्णित है। सिग्नल्स एक व्यापक श्रृंखला के तकनीकी विश्लेषण संकेतकों पर आधारित हैं

Total Execution Time: 2.1394379138947 seconds
Number of API calls: 3
Number of DB calls: 9